-
March 2017
StemBioSys Licenses Additional Technology From UT Health San Antonio To Expand Existing Portfolio on Stem Cell-Enabling Technologies
SAN ANTONIO – StemBioSys Inc. announced today that it has licensed additional technology from UT Health™ San Antonio that expands the company’s intellectual property portfolio aimed at enabling the expansion of adult stem cells for therapeutic use. To date StemBioSys has converted three pending patents originally licensed from UT Health™ San Antonio into eight issued […]
-
January 2017
GenCure, StemBioSys forge stem cell product manufacturing agreement
GenCure will be exclusive producer for StemBioSys-developed regenerative medicine products. SAN ANTONIO – GenCure, a subsidiary of San Antonio-based biotech BioBridge Global, has entered a development and manufacturing agreement with stem cell technology developer StemBioSys Inc. of San Antonio. In the agreement, GenCure will be the exclusive manufacturer for cell-based products that StemBioSys has developed […]
-
January 2017
StemBioSys Announces US and Canadian Distribution Agreement with VWR
SAN ANTONIO – StemBioSys Inc. announced today that it has entered into an agreement with VWR (NASDAQ: VWR) to distribute and market StemBioSys products. VWR, the leading global independent provider of product and service solutions to laboratory and production facilities, will be the exclusive distributor for StemBioSys in both the United States and Canada. “I […]
-
October 2016
BioBridge Global-led biotech team awarded $7.8 million Army contract
Funds will help group develop capability for large-scale manufacturing of stem cells for research and patient use. SAN ANTONIO – A four-organization biotech group led by San Antonio-based nonprofit BioBridge Global (BBG), has been awarded a $7.8 million contract from the Medical Technology Enterprise Consortium (MTEC). The funds will enable the development of large-scale manufacturing […]
-
August 2016
StemBioSys Announces European Distribution Agreement with Cellaviva AB of Sweden
SAN ANTONIO – StemBioSys Inc. announced today that it has entered into an agreement with Cellaviva AB to distribute and market StemBioSys products. Cellaviva will be the exclusive distributor for StemBioSys in Sweden and Denmark. The agreement also grants nonexclusive rights to Cellaviva for the remainder of Europe. Initially, the agreement will cover StemBioSys’ cell […]